Soft bones and hard arteries-can we reverse the trend in CKD?
Related Experiment Video
Updated: Jun 25, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
James Tomlinson1, John Cunningham
1The Centre for Nephrology, University College and The Royal Free Medical School, London NW3 2PF, UK.
Insights
Chronic kidney disease-bone and mineral disorder (CKD-MBD) involves complex interactions affecting bone health and fracture risk. Understanding CKD-MBD pathophysiology is crucial for refining treatments and managing vascular calcification risks.
Area of Science:
- Nephrology
- Endocrinology
- Bone Biology
Background:
- Chronic kidney disease-bone and mineral disorder (CKD-MBD) is a complex condition.
- It involves dysregulation of calcium, phosphorus, and hormones.
- CKD-MBD is linked to impaired bone mineralization and increased fracture risk.
Purpose of the Study:
- To review advances in understanding CKD-MBD pathophysiology.
- To discuss therapeutic approaches for CKD-MBD.
- To address the challenge of vascular calcification (VC) in CKD patients.
Main Methods:
- Literature review of recent research on CKD-MBD.
- Analysis of pathophysiological mechanisms.
- Discussion of current and emerging therapeutic strategies.
Main Results:
- Significant advances in understanding CKD-MBD.
- Identification of links between CKD-MBD and vascular calcification.
- Recognition of therapeutic challenges, including side effects like VC.
Conclusions:
- CKD-MBD is a multifaceted disorder requiring integrated management.
- Further research is needed to refine therapies and mitigate risks like VC.
- Improved understanding of pathophysiology aids in developing better treatment strategies.
Abstract:
Chronic kidney disease-bone and mineral disorder (CKD-MBD) signifies the complex pathophysiological interactions between calcium, phosphorus and regulatory hormones which are associated, sometimes causally, with impaired bone mineralisation and increased fracture risk in patients with CKD. It also signifies a predisposition to vascular calcification (VC), the emergence of which as a likely side effect of some of the current therapies poses a difficult problem for physicians aiming to treat patients with CKD. This complex disorder has seen several important advances in relation to understanding of the pathophysiology and, it is hoped, refinement of therapeutic approaches.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

